Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €20.18 EUR
Change Today +0.05 / 0.25%
Volume 6.2K
REG1V On Other Exchanges
As of 11:29 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

revenio group oyj (REG1V) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/13/15 - €24.95
52 Week Low
10/16/14 - €13.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for REVENIO GROUP OYJ (REG1V)

Related News

No related news articles were found.

revenio group oyj (REG1V) Related Businessweek News

No Related Businessweek News Found

revenio group oyj (REG1V) Details

Revenio Group Oyj designs, manufactures, and sells medical instruments used for measuring intraocular pressure and bone density. The company operates in two segments: Revenio Health Tech and Revenio Technology and Services. The Revenio Health Tech segment designs, manufactures, and sells tonometers and disposable probes, and bone density measurement devices. The Revenio Technology and Services segment offers software for indoor logistics automation systems; manufactures and sells rigid inflatable boats; and provides contact center services. The company is headquartered in Vantaa, Finland.

revenio group oyj (REG1V) Top Compensated Officers

Chief Executive Officer, President and Segmen...
Total Annual Compensation: €226.3K
Compensation as of Fiscal Year 2013.

revenio group oyj (REG1V) Key Developments

Revenio Group Corporation Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Year 2015

Revenio Group Corporation reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales from continuing operations of EUR 4.6 million compared to EUR 3.7 million for the same period a year ago. EBITDA from continuing operations was EUR 1.5 million compared to EUR 1.2 million last year. Operating profit from continuing operations was EUR 1.4 million compared to EUR 1.1 million last year. Pre-tax profit from continuing operations was EUR 1.6 million compared to EUR 1.1 million last year. Net profit from continuing operations was EUR 1.2 million or EUR 0.15 per diluted share compared to EUR 1.0 million or EUR 0.12 per undiluted and diluted share last year. Net profit was EUR 1.5 million compared to EUR 1.0 million last year. Net profit attributable to parent company shareholders was EUR 1.5 million compared to EUR 1.0 million last year. Cash flow from operations was EUR 3.1 million compared to EUR 0.1 million a year ago. The group's purchases of PPE and intangible assets totaled EUR 0.5 million compared to EUR 0.3 million a year ago. Gross capital expenditure was EUR 0.5 million compared to EUR 0.3 million a year ago. Return on investment was 32.6% compared to 26.3% last year. Return on equity was 55.2% compared to 27.4% last year. For the year 2015, the net sales and operating profit of Icare are expected to grow from last year. Investments in new business operations related to health tech, which have an impact on consolidated operating profit and cash flow. No significant investments will be made in 2015.

Revenio Group Corporation Amends Articles of Association

Revenio Group Corporation announced that AGM was held on March 19, 2015, the shareholders approve the amendments of the Articles of Association.

Revenio Group Corporation Proposes Dividend, Payable on March 30, 2015

Revenio Group Corporation announced that at the AGM of 2015, the company proposes resolution on the use of the profit shown on the balance sheet and the payment of dividend. The Board of Directors proposes to the AGM that a per-share dividend of EUR 0.45 be paid for the financial year 2014. The dividend is paid to those shareholders who, on the dividend record date of March 23, 2015, are entered as shareholders on the Company's shareholder register as held by Euroclear Finland Ltd. The Board proposes that the dividend payment date be March 30, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REG1V:FH €20.18 EUR +0.05

REG1V Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for REG1V.
View Industry Companies

Industry Analysis


Industry Average

Valuation REG1V Industry Range
Price/Earnings 41.0x
Price/Sales 9.3x
Price/Book 15.8x
Price/Cash Flow 503.3x
TEV/Sales 9.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REVENIO GROUP OYJ, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at